Jane Street
HRTX icon

Jane Street’s Heron Therapeutics HRTX Stock Holding History

Jane Street’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Buy
31,200
+14,600
+88% +$16.9K ﹤0.01% 11153
2025
Q4 		$21.6K Sell
16,600
-3,500
-17% -$4.32K ﹤0.01% 10710
2025
Q3 		$25.3K Buy
+20,100
New +$31.9K ﹤0.01% 10492
2025
Q2 		– Sell
-413,800
Closed -$910K – 10153
2025
Q1 		$910K Buy
+413,800
New +$803K ﹤0.01% 5746
2024
Q2 		– Sell
-494,800
Closed -$1.37M – 9724
2024
Q1 		$1.37M Buy
+494,800
New +$1.24M ﹤0.01% 4823
2022
Q4 		– Sell
-12,100
Closed -$51K – 9532
2022
Q3 		$51K Buy
+12,100
New +$47.3K ﹤0.01% 8918
2022
Q2 		– Sell
-13,600
Closed -$78K – 10132
2022
Q1 		$78K Sell
13,600
-14,500
-52% -$106K ﹤0.01% 9544
2021
Q4 		$257K Sell
28,100
-37,900
-57% -$387K ﹤0.01% 8441
2021
Q3 		$706K Sell
66,000
-88,800
-57% -$1.08M ﹤0.01% 6627
2021
Q2 		$2.4M Buy
154,800
+131,500
+564% +$2.09M ﹤0.01% 3977
2021
Q1 		$378K Buy
23,300
+11,500
+97% +$205K ﹤0.01% 7313
2020
Q4 		$250K Buy
+11,800
New +$205K ﹤0.01% 6665
2020
Q3 		– Sell
-46,400
Closed -$683K – 7463
2020
Q2 		$683K Buy
+46,400
New +$762K ﹤0.01% 4612
2018
Q3 		– Sell
-22,100
Closed -$859K – 5358
2018
Q2 		$859K Buy
+22,100
New +$704K ﹤0.01% 2941

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jane Street's HRTX Position: Q1 2026 in Review

Jane Street sold out of Heron Therapeutics (HRTX) in Q1 2026, closing a stake of 1,367,891 shares — an estimated $1.59M sold.

Jane Street first reported a position in HRTX in Q1 2014 and held it in 35 quarters. The position peaked at $1.78M in Q4 2025. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Jane Street reported no remaining Heron Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,367,891 Heron Therapeutics shares in Q1 2026, an estimated $1.59M.
  • Jane Street first reported a position in Heron Therapeutics in Q1 2014 and held it in 35 quarters.
  • Jane Street's Heron Therapeutics position peaked at $1.78M in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.